Your session is about to expire
← Back to Search
Palliative Care for Advanced Dementia
N/A
Waitlist Available
Research Sponsored by University of Maryland, Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up collected upon admission to the nursing home and again 14-21 days post-admission to the nursing home
Awards & highlights
Study Summary
This trial found that 40% of US nursing home residents with advanced dementia received skilled nursing facility care in their last 90 days, and this care was associated with poorer outcomes, including a higher risk of dying in a hospital.
Who is the study for?
This trial is for individuals aged 60 or older with Alzheimer's disease or related dementias (ADRD) who are admitted to a skilled nursing facility after hospitalization. They should need palliative care, as indicated by certain health signs like frequent admissions or weight loss. A legal representative can consent if the patient cannot.Check my eligibility
What is being tested?
The study tests the effectiveness of palliative care consultations for those with advanced dementia in skilled nursing facilities. It aims to see if this approach improves end-of-life outcomes compared to standard aggressive therapies that often lead to poorer results.See study design
What are the potential side effects?
Palliative care focuses on comfort rather than side effects from treatments; however, emotional distress and changes in mood may occur as patients and families discuss end-of-life preferences and manage symptoms.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ collected upon admission to the nursing home and again 14-21 days post-admission to the nursing home
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~collected upon admission to the nursing home and again 14-21 days post-admission to the nursing home
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Patient/Caregiver Quality of Life
Secondary outcome measures
Satisfaction with Care
Symptom Management
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Palliative Care ConsultExperimental Treatment1 Intervention
Participants will receive the standard Medicare Skilled Nursing Facility care plus a Palliative Care Consultation with a trained provider.
Group II: Standard CareActive Control1 Intervention
Participants will receive the standard Medicare Skilled Nursing Facility care.
Find a Location
Who is running the clinical trial?
University of Maryland, BaltimoreLead Sponsor
687 Previous Clinical Trials
374,639 Total Patients Enrolled
2 Trials studying Palliative Care
61 Patients Enrolled for Palliative Care
National Institute on Aging (NIA)NIH
1,669 Previous Clinical Trials
28,005,107 Total Patients Enrolled
10 Trials studying Palliative Care
28,193 Patients Enrolled for Palliative Care
National Institute of Nursing Research (NINR)NIH
579 Previous Clinical Trials
10,376,375 Total Patients Enrolled
8 Trials studying Palliative Care
1,668 Patients Enrolled for Palliative Care
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Standard Care
- Group 2: Palliative Care Consult
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any open enrollment opportunities for this experiment?
"According to the clinicaltrials.gov website, this medical trial is not presently recruiting patients: it was initially posted on June 15th 2022 and modified for a final time on July 12th 2022. Nonetheless, there are 59 other trials that currently need participants."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger